E‐cigarette or vaping product use‐associated lung injury (EVALI) features and recognition in the eme...
E‐cigarette or vaping product use‐associated lung injury (EVALI) features and recognition in the emergency department
About this item
Full title
Author / Creator
Publisher
United States: John Wiley and Sons Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley and Sons Inc
Subjects
More information
Scope and Contents
Contents
AbstractSince August 2019, the pulmonary disease termed e‐cigarette or vaping product‐use associated lung injury (EVALI), has resulted in 2758 hospitalizations and 64 deaths in the United States. EVALI is considered in patients who have vaped or dabbed within 90 days of symptom onset, and have abnormal lung imaging in the absence of any pulmonary i...
Alternative Titles
Full title
E‐cigarette or vaping product use‐associated lung injury (EVALI) features and recognition in the emergency department
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_491f40be668d457ebd48d12bde561332
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_491f40be668d457ebd48d12bde561332
Other Identifiers
ISSN
2688-1152
E-ISSN
2688-1152
DOI
10.1002/emp2.12112
